Early-Stage Innovative Technology Development for Cancer Research Program

by:

The National Institutes of Health, otherwise known as the NIH, is an agency operating within the United States Department of Health and Human Services that is primarily responsible for pursuing and financially supporting most of the country's biomedical and health-related research.

The programs and initiatives of the NIH are designed to contribute to the achievement of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In accordance with this mission, the National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

The research studies that are covered under this program could also focus on emerging technology, which means includes the kind of technologies that have just been started or discovered, and have not yet been tested or evaluated. In this regard, the NIH and NCI wants the applicants and investigators to explore this technologies, with the goal of potentially making them better and more efficient.

  (continued...)

Early-Stage Innovative Technology Development for Cancer Research Program
  Page 2

About The Author

The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs.

The staff also provides resources to other Websites with information on artist grants and children grants.




Additional Resources



category - Health Grants

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.


2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).


Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.


Health Resources and Services Administration: HIV Care Grant Program, Part B
Part B of the HIV Care Grant Program is designed to develop or improve the people's access to a comprehensive continuum of high-quality, community-based care for low-income patients diagnosed with HIV.






Gradian Health Systems, which pioneered the CE-marked Universal Anaesthesia Machine to bring general anaesthesia in underserved communities around the world on patients of any age, is a Limited Liability Corporation (LLC) solely owned by a New York City-based private foundation, the Nick Simons Foundation.




Not for Profit Jobs in Nebraska

  Executive Director Jobs
  Substance Abuse Jobs
  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs